MiraVista Diagnostics’ dedication to innovation and improved accessibility to high quality fungal diagnotics has created a Histoplasma Urine Antigen LFA.
MiraVista Diagnostics is leading the industry with a new Histoplama Urine Antigen LFA. The rapid, non-invasive test demonstrates 96% correlation with the MiraVista Histoplasma Antigen Quantitative EIA, can be operated in low complexity clinical settings and requires no additional materials or equipment.
Key Benefits and Features
Rapid diagnosis can help treatment begin more quickly, reduce duration of anti-fungal therapy and help the patient recover faster.
